Compare Mekophar Chemical Pharmaceutical JSC with Similar Stocks
Stock DNA
Pharmaceuticals & Biotechnology
VND 258,874 Million ()
NA (Loss Making)
NA
4.88%
-0.09
-0.83%
0.21
Revenue and Profits:
Net Sales:
207,863 Million
(Quarterly Results - Mar 2026)
Net Profit:
1,617 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-20.41%
0%
-20.41%
6 Months
-2.18%
0%
-2.18%
1 Year
-2.18%
0%
-2.18%
2 Years
-20.65%
0%
-20.65%
3 Years
-0.37%
0%
-0.37%
4 Years
-43.72%
0%
-43.72%
5 Years
0%
0%
0.0%
Mekophar Chemical Pharmaceutical JSC for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
-1.73%
EBIT Growth (5y)
-184.22%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.14
Sales to Capital Employed (avg)
194,901.75
Tax Ratio
36.50%
Dividend Payout Ratio
30.98%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
14.55%
ROE (avg)
11.43%
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.26
EV to EBIT
-2.66
EV to EBITDA
-9.60
EV to Capital Employed
0.13
EV to Sales
0.14
PEG Ratio
NA
Dividend Yield
3.90%
ROCE (Latest)
-4.74%
ROE (Latest)
-0.83%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Mildly Bullish
Dow Theory
Bearish
No Trend
OBV
No Trend
Mildly Bearish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY
Mar'26
Mar'25
Change(%)
Net Sales
207,862.80
229,661.60
-9.49%
Operating Profit (PBDIT) excl Other Income
12,132.70
-2,928.40
514.31%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
1,617.30
-13,452.60
112.02%
Operating Profit Margin (Excl OI)
0.80%
-64.00%
6.48%
USD in Million.
Net Sales
YoY Growth in quarter ended Mar 2026 is -9.49% vs -6.38% in Mar 2025
Consolidated Net Profit
YoY Growth in quarter ended Mar 2026 is 112.02% vs -194.61% in Mar 2025
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
919,577.50
904,746.60
1.64%
Operating Profit (PBDIT) excl Other Income
38,882.00
55,542.10
-30.00%
Interest
0.00
500.90
-100.00%
Exceptional Items
0.00
17,366.80
-100.00%
Consolidate Net Profit
40,785.30
21,161.10
92.74%
Operating Profit Margin (Excl OI)
-9.30%
7.80%
-1.71%
USD in Million.
Net Sales
Not Applicable: The company has declared_date for only one period
Consolidated Net Profit
Not Applicable: The company has declared_date for only one period
About Mekophar Chemical Pharmaceutical JSC 
Mekophar Chemical Pharmaceutical JSC
Pharmaceuticals & Biotechnology
Mekophar Chemical Pharmaceutical Joint-Stock Company (Mekophar) is a Vietnam-based company engaged in the pharmaceutical industry. The Company manufactures, trades and distributes drugs, as well as chemicals and raw materials for drug manufacturing. It also manufactures and trades medical equipment and packaging, such as plastic bottles, carton boxes and paper containers. In addition, Mekophar is active in office and apartment leasing, as well as cosmetic manufacturing and trading.
Company Coordinates 
Company Details
297/5 Ly Thuong Kiet, Quan 11 , HO CHI MINH None : None
Registrar Details






